Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 10/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 9/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 9/20 | 1.00 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etorphine SCHEMBL25681403 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL12125405 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL15013782 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL12230551 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL140251 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL19565627 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL19564457 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL10031275 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL14516216 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 | |
| Etorphine SCHEMBL29381660 | 1.00 | OPRK1 (1.00) | OPRK1OPRM1OPRD1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 20309 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-12564597-B2 | Ibogaine analogs as therapeutics for neurological and psychiatric disorders | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE OF NEW YORK (US) | 2026-03-03 | — | — | US | claimed |
| US-12472202-B2 | Compositions and their use in the treatment of endometriosis and pain | RR Medsciences PTY, LTD (AU) | 2025-11-18 | — | — | US | claimed |
| US-12440489-B2 | Organic compounds | INTRA-CELLULAR THERAPIES, INC. (US) | 2025-10-14 | — | — | US | claimed |
| US-20250283129-A1 | PROCESS | SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED (AU) | 2025-09-11 | — | — | US | claimed |
| US-12383743-B2 | Treatment of addiction and dependency | TACA JR ARTURO C (US) | 2025-08-12 | — | — | US | claimed |
| US-20250228771-A1 | ALKALINE INTRAORAL PRODUCTS | EMPLICURE AB (publ) (SE) | 2025-07-17 | — | — | US | claimed |
| EP-4565202-A1 | ALKALINE INTRAORAL PRODUCTS | EMPLICURE AB (publ) (SE) | 2025-06-11 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-0170090-B1 | SUBSTITUTED BENZOATE ESTER PRODRUG DERIVATIVES OF 3-HYDROXYMORPHINANS, INTERMEDIATES THERETO, AND PROCESSES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-09-27 | — | — | EP | claimed |
| US-4829056-A | MONOSACCHARIDES, DISACCHARIDES, XANTHAN GUM, LOCUST BEAN GUM | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1989-05-09 | — | — | US | claimed |
| EP-0250796-A2 | Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-01-07 | — | — | EP | claimed |
| EP-0245952-A2 | Buccal tablet comprising etorphine or a salt thereof | RECKITT AND COLMAN PRODUCTS LIMITED (GB) | 1987-11-19 | — | — | EP | claimed |
| EP-0243797-A2 | Method for amplifying enzyme activity, enzyme conjugates suitable therefor and their preparation | NORTHEASTERN UNIVERSITY (US) | 1987-11-04 | — | — | EP | claimed |
| US-4673679-A | ESTERS, CARBONATES, CARBAMATES, OR SULFONATES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-06-16 | — | — | US | claimed |
| US-4668685-A | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-05-26 | — | — | US | claimed |
| EP-0170090-A1 | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, intermediates thereto, and processes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-02-05 | — | — | EP | claimed |
| US-4473640-A | OF DRUG-GLUCURONIC ACID COMPLEXES | COMBIE JOAN D | 1984-09-25 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |